Search Results - Vilacha, Juliana F.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment

    Making NSCLC Crystal Clear: How Kinase Structures Revolutionized Lung Cancer Treatment by Vilachã, Juliana F., Mitchel, Sarah C., Akele, Muluembet Z., Evans, Stephen, Groves, Matthew R.

    Published in Crystals (Basel)
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance

    Feasibility of Follow-Up Studies and Reclassification in Spinocerebellar Ataxia Gene Variants of Unknown Significance by Ghorbani, Fatemeh, Alimohamed, Mohamed Z, Vilacha, Juliana F, Van Dijk, Krista K, De Boer-Bergsma, Jelkje, Fokkens, Michiel R, Lemmink, Henny, Sijmons, Rolf H, Sikkema-Raddatz, Birgit, Groves, Matthew R, Verschuuren-Bemelmans, Corien C, Verbeek, Dineke S, Van Diemen, Cleo C, Westers, Helga

    Published in Frontiers in genetics
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC

    Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC by van Kempen, Léon C., Wang, Hangjun, Aguirre, Maria Leonor, Spatz, Alan, Kasymjanova, Goulnar, Vilacha, Juliana F., Groves, Matthew R., Agulnik, Jason, Small, David

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Structural Aspects of the ROS1 Kinase Domain and Oncogenic Mutations

    Structural Aspects of the ROS1 Kinase Domain and Oncogenic Mutations by Vilachã, Juliana F, Wassenaar, Tsjerk A, Marrink, Siewert J

    Published in Crystals (Basel)
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  5. 5
    Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature

    Actionability of on-target ALK Resistance Mutations in Patients With Non-Small Cell Lung Cancer: Local Experience and Review of the Literature by Koopman, Bart, Groen, Harry J.M., Schuuring, Ed, Hiltermann, T. Jeroen N., Timens, Wim, den Dunnen, Wilfred F.A., van den Berg, Anke, ter Elst, Arja, van Kruchten, Michel, Kluiver, Joost L., Hiddinga, Birgitta I., Hijmering-Kappelle, Lucie B.M., Groves, Matthew R., Vilacha, Juliana F., van Kempen, Léon C., van der Wekken, Anthonie J.

    Published in Clinical lung cancer
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Abstract 1398: Modeling of drug-protein interactions to support clinical decision making for therapy-resistant EGFR or ALK -positive non-small cell lung carcinoma

    Abstract 1398: Modeling of drug-protein interactions to support clinical decision making for therapy-resistant EGFR or ALK -positive non-small cell lung carcinoma by Santos, Juliana F. Vilacha Madeira R, Hiddinga, Birgitta I., Kempen, Leon C. van, Elst, Arja ter, Hijmering, Lucie B., Hiltermann, Thijo J., Schuuring, Ed, Groves, Matthew R., Groen, Harry J., Wekken, Anthonie J. van der

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: